5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.00▲ | 1.00▲ | 1.00▲ | 0.96▲ | 0.93▲ |
MA10 | 0.97▲ | 0.97▲ | 0.96▲ | 0.93▲ | 0.95▲ |
MA20 | 0.95▲ | 0.95▲ | 0.94▲ | 0.92▲ | 0.94▲ |
MA50 | 0.92▲ | 0.91▲ | 0.91▲ | 0.96▲ | 1.07▼ |
MA100 | 0.90▲ | 0.94▲ | 0.99▲ | 0.92▲ | 1.33▼ |
MA200 | 1.00▲ | 0.98▲ | 0.97▲ | 1.05▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.008▲ | 0.010▲ | 0.011▲ | 0.012▲ | 0.016▲ |
RSI | 63.603▲ | 62.971▲ | 62.214▲ | 57.599▲ | 50.933▲ |
STOCH | 96.044▲ | 92.473▲ | 79.806 | 68.096 | 27.620 |
WILL %R | -23.734▲ | -15.789▲ | -15.789▲ | -23.810▲ | -65.448 |
CCI | 144.064▲ | 131.981▲ | 139.336▲ | 210.829▲ | 30.771 |
Friday, April 25, 2025 10:12 AM
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines ...
|
Friday, April 25, 2025 10:00 AM
Preclinical data further support the potential of dual-antigen and TGF-β-directed vaccines to reshape the tumor microenvironment and drive anti-tumor immunity NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) ...
|
Friday, April 25, 2025 03:00 AM
IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced the presentation of new ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 0.9724 | 1.06 | 0.9724 | 1.01 | 72,802 |
30/04/25 | 0.9166 | 0.97 | 0.9166 | 0.97 | 42,711 |
29/04/25 | 0.9299 | 0.9299 | 0.9236 | 0.9236 | 55,058 |
28/04/25 | 0.95 | 0.9604 | 0.9105 | 0.9501 | 50,182 |
25/04/25 | 0.93 | 1.00 | 0.85 | 0.96 | 213,632 |
24/04/25 | 0.95 | 0.95 | 0.91 | 0.9228 | 63,518 |
23/04/25 | 0.95 | 0.9651 | 0.92 | 0.94 | 85,731 |
22/04/25 | 0.9064 | 0.93 | 0.89 | 0.908 | 99,280 |
21/04/25 | 0.8535 | 0.91 | 0.8535 | 0.8894 | 68,374 |
17/04/25 | 0.875 | 0.92 | 0.86 | 0.8601 | 41,255 |
|
|
||||
|
|
||||
|
|